These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35231915)

  • 21. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).
    Kindgen-Milles D; Brandenburger T; Braun JFW; Cleff C; Moussazadeh K; Mrosewski I; Timm J; Wetzchewald D
    PLoS One; 2021; 16(4):e0248813. PubMed ID: 33831032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis.
    Dhochak N; Jat KR; Soni KD; Singh Y; Aggarwal R; Lodha R; Trikha A; Kabra SK
    Indian J Pediatr; 2022 Apr; 89(4):404-406. PubMed ID: 35089489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma and COVID-19: an update.
    Adir Y; Saliba W; Beurnier A; Humbert M
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study.
    Meng M; Wei R; Wu Y; Zeng R; Luo D; Ma Y; Zhang L; Huang W; Zeng H; Leung FW; Qiu X; Sha W; Chen H
    EClinicalMedicine; 2024 Mar; 69():102500. PubMed ID: 38389713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting pulmonary rehabilitation during COVID-19 pandemic: a narrative review.
    Dixit S; Borghi-Silva A; Bairapareddy KC
    Rev Cardiovasc Med; 2021 Jun; 22(2):315-327. PubMed ID: 34258900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
    Papaioannou AI; Fouka E; Tzanakis N; Antoniou K; Samitas K; Zervas E; Kostikas K; Bartziokas K; Porpodis K; Papakosta D; Tzouvelekis A; Gerogianni I; Kotsiou O; Makris M; Rovina N; Vlachou G; Markatos M; Vittorakis S; Katsoulis K; Papanikolaou I; Afthinos A; Katsaounou P; Steiropoulos P; Latsios D; Dimakou K; Koukidou S; Hillas G; Tryfon S; Kallieri M; Georgopoulou A; Avarlis P; Bakakos P; Markopoulou K; Gaki E; Paspala A; Kyriakaki Z; Gourgoulianis KI; Papiris S; Loukides S
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2588-2595. PubMed ID: 35752436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study.
    Beltramo G; Cottenet J; Mariet AS; Georges M; Piroth L; Tubert-Bitter P; Bonniaud P; Quantin C
    Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34016619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes Among Patients Hospitalized With Non-COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada.
    McAlister FA; Chu A; Qiu F; Dong Y; van Diepen S; Youngson E; Yu AYX; de Mestral C; Ross HJ; Austin PC; Lee DS; Kadri SS; Wijeysundera HC;
    JAMA Netw Open; 2023 Jul; 6(7):e2323035. PubMed ID: 37436751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Pandemic Lesson for Global Lung Diseases: Exacerbations Are Preventable.
    Cookson W; Moffatt M; Rapeport G; Quint J
    Am J Respir Crit Care Med; 2022 Jun; 205(11):1271-1280. PubMed ID: 35192447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
    Javelot H; Llorca PM; Drapier D; Fakra E; Hingray C; Meyer G; Dizet S; Egron A; Straczek C; Roser M; Masson M; Gaillard R; Fossati P; Haffen E
    Encephale; 2020 Jun; 46(3S):S14-S34. PubMed ID: 32376004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of airborne transmission of SARS-CoV-2 on COVID-19 pandemic. A review.
    Domingo JL; Marquès M; Rovira J
    Environ Res; 2020 Sep; 188():109861. PubMed ID: 32718835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Society of swallowing and dysphagia of Japan: Position statement on dysphagia management during the COVID-19 outbreak.
    Kimura Y; Ueha R; Furukawa T; Oshima F; Fujitani J; Nakajima J; Kaneoka A; Aoyama H; Fujimoto Y; Umezaki T
    Auris Nasus Larynx; 2020 Oct; 47(5):715-726. PubMed ID: 32736887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic.
    Shao C; Shi Y; Chen R; Liu X; Huang H; Zhao Y; Xu K; Chen K; Wang M; Xu Z
    J Med Virol; 2023 Sep; 95(9):e29098. PubMed ID: 37707416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.
    Colombo C; Cipolli M; Daccò V; Medino P; Alghisi F; Ambroni M; Badolato R; Battistini F; Bignamini E; Casciaro R; Ciciriello F; Collura M; Comello I; Francalanci M; Ficili F; Folino A; Leonardi S; Leonetti G; Lucanto MC; Lucca F; Maschio M; Mencarini V; Messore B; Pisi G; Pizzamiglio G; Poli P; Raia V; Riberi L; Ros M; Rotolo N; Sepe A; Taccetti G; Vitullo P; Alicandro G
    Infection; 2022 Jun; 50(3):671-679. PubMed ID: 34874541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.